Literature DB >> 7812787

Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study.

S J Chrapusta1, M F Egan, J M Masserano, R J Wyatt.   

Abstract

Multiple lines of evidence indicate dopamine is a neurotransmitter or neuromodulator in the cerebellum and hippocampus. In this study, we explored the utility of 3-methoxytyramine as an index of dopamine release in these regions. We found that: (1) cerebellar and hippocampal 3-methoxytyramine levels can be measured by combined gas chromatography-mass fragmentography with negative chemical ionization; (2) basal 3-methoxytyramine accumulation rates following monoamine oxidase inhibition, but not the steady-state tissue levels, are several times lower in these regions than in the frontal cortex; (3) accumulation of 3-methoxytyramine in the hippocampus and cerebellum can be enhanced following electroconvulsive shock, but not acute haloperidol (0.4 mg/kg) treatment. We conclude that 3-methoxytyramine accumulation may be a useful index of dopamine release in the cerebellum and hippocampus, but dopamine release is regulated differently in these regions than in the frontal cortex and striatum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812787     DOI: 10.1016/0006-8993(94)91627-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  1 in total

1.  Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.

Authors:  Mitsuko Hamamura; Hidetoshi Ozawa; Miwako Ozaki; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2010-08-03       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.